Clinical-related and Lab Services ("CRLS") ● Tigermed Segment Revenue (RMB mm) 1,422.1 +13.0% 1,607.5 Gross Profit and Margin 43.4% (RMB mm) 39.9% +3.8% 617.6 640.8 1H2022 1 H2023 1 H2022 1H2023 18

View entire presentation